skip to main content

H.R. 5763 (114th): Prostate Cancer Misdiagnosis Elimination Act of 2016


We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Jul 13, 2016.


Prostate Cancer Misdiagnosis Elimination Act of 2016

This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.